TLSI — TriSalus Life Sciences Inc.

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About TriSalus Life Sciences Inc.

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$3.22
Market Cap$199M
Float51.5M
Shares Outstanding61.4M
Price/Sales (TTM)4.43
vs. Analyst Target+173.3% to analyst PT
Profit Margin-60.85%
Operating Margin (TTM)-94.52%
Revenue (TTM)$44.9M
Dividend RateNone
Analyst Target Price$8.80 (8 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2021 $8.4M -$28.8M $7.2M -$23.6M
2022 $12.4M -$47.2M $10.1M -$46.8M
2023 $18.5M -$59.4M $15.9M -$58.7M
2024 $29.4M -$33.2M $25.3M -$36.2M
2025 $45.2M -$39.2M $38.2M -$26.9M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $11.2M -$8.3M
Sep 2025 $11.6M -$10.8M
Dec 2025 $13.2M -$9.8M
Mar 2026 $8.9M $1.5M

Ownership & Float

Insider Ownership28.9%
Institutional Ownership34.4%
Short Float2.8%
% of All Funds Holding0.90%
Number of Funds Holding74

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$3.96Near-term / short-term trend
Weekly40-Week SMA$4.94Medium-term trend
Weekly80-Week SMA$5.01Cyclical trend (business cycle)
Weekly200-Week SMA$6.93Secular trend (multi-year)
Monthly10-Month SMA$5.00Near-term monthly trend
Monthly20-Month SMA$4.99Medium-term monthly trend
Monthly40-Month SMA$6.38Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$4.40 resistance 3.31x 0 months ago
$5.00 resistance 1.65x 1 months ago
$6.90 resistance 1.18x 3 months ago

Historical Earnings Reactions (21 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -1.17% 0.00% 47.62% 5.67% -21.05%
1 Day -2.13% 0.00% 47.62% 8.22% -41.45%
1 Week -0.54% -0.10% 47.62% 40.27% -29.10%
2 Weeks 2.93% 0.05% 50.00% 59.45% -25.07%
1 Month 6.88% 0.33% 60.00% 104.25% -24.25%

Next earnings: July 31, 2026 (65 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.00% 47.6% 246
Tuesday 0.02% 41.1% 275
Wednesday -0.22% 38.1% 273
Thursday 0.09% 46.2% 266
Friday 0.00% 40.7% 268

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 34.4%

Insider Transactions — Smart Summary

Total insider ownership: 28.9%

12-Month Insider Activity Summary

Total Filings16
Net Value+$124,211.709
Net Shares Change1,128,044
% of Float2.2%
C-Suite Filings10
Clusters Detected3

Key Insiders

NameTitleNet ValueFilingsActivity
Stansky Michael P +$3.0M 2 4 buy
Szela Mary T CEO and President +$227,773.08 2 1 buy
Wahlstrom Mats +$151,800 1 1 buy
Valle William +$124,996.7 1 1 buy
Gordon Gary B. +$64,599.6 2 2 buy
Patience David Chief Financial Officer +$32,246.7 2 2 buy

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-02-23 – 2026-02-23 5 5 +$1.8M 2 C-suite
2026-03-20 – 2026-03-20 5 5 -$134,358.261 5 C-suite
2026-05-18 – 2026-05-19 6 6 +$1.8M 3 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-05-18 Stansky Michael P +$1.5M Transaction at $2.50, now +28.8%
2026-05-18 Patience David Chief Financial Officer +$17,253 Transaction at $2.43, now +32.5%
2026-05-18 Gordon Gary B. +$24,600 Transaction at $2.46, now +30.9%
2026-05-18 Wahlstrom Mats +$151,800 Transaction at $2.53, now +27.3%
2026-02-23 Stansky Michael P +$1.5M Transaction at $4.10, now -21.5%
2026-02-23 Szela Mary T CEO and President +$124,996.7 Transaction at $4.10, now -21.5%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for TriSalus Life Sciences Inc. (TLSI) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for TLSI on Trend Edge →